For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Gossamer Bio Inc (NASDAQ: GOSS) was $0.67 for the day, down -0.30% from the previous closing price of $0.67. In other words, the price has decreased by -$0.30 from its previous closing price. On the day, 2.08 million shares were traded. GOSS stock price reached its highest trading level at $0.71 during the session, while it also had its lowest trading level at $0.6529.
Ratios:
Our analysis of GOSS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.94 and its Current Ratio is at 5.94. In the meantime, Its Debt-to-Equity ratio is 3.38 whereas as Long-Term Debt/Eq ratio is at 3.15.
On July 27, 2023, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $8 to $1.25.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 27 ’24 when Hasnain Faheem sold 23,172 shares for $1.16 per share. The transaction valued at 26,773 led to the insider holds 120,293 shares of the business.
Giraudo Bryan sold 6,430 shares of GOSS for $7,431 on Mar 27 ’24. The COO/CFO now owns 92,737 shares after completing the transaction at $1.16 per share. On Mar 27 ’24, another insider, Christian Waage, who serves as the EVP, Tech Ops and Admin of the company, sold 6,430 shares for $1.16 each. As a result, the insider received 7,430 and left with 585,934 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GOSS now has a Market Capitalization of 150688768 and an Enterprise Value of 66727944.
Stock Price History:
The Beta on a monthly basis for GOSS is 1.84, which has changed by -0.4939394 over the last 52 weeks, in comparison to a change of 0.22363698 over the same period for the S&P500. Over the past 52 weeks, GOSS has reached a high of $1.88, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is -42.49%, while the 200-Day Moving Average is calculated to be -31.65%.
Shares Statistics:
GOSS traded an average of 1.36M shares per day over the past three months and 1193410 shares per day over the past ten days. A total of 225.41M shares are outstanding, with a floating share count of 189.41M. Insiders hold about 16.27% of the company’s shares, while institutions hold 79.19% stake in the company. Shares short for GOSS as of 1713139200 were 11112453 with a Short Ratio of 8.17, compared to 1710460800 on 11086247. Therefore, it implies a Short% of Shares Outstanding of 11112453 and a Short% of Float of 5.79.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 9.0 analysts currently analyzing and rating the stock of Gossamer Bio Inc (GOSS).On average, analysts expect EPS of -$0.19 for the current quarter, with a high estimate of -$0.15 and a low estimate of -$0.23, while EPS last year was -$0.52. The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.14 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$0.59 and -$0.94 for the fiscal current year, implying an average EPS of -$0.76. EPS for the following year is -$0.7, with 10.0 analysts recommending between -$0.46 and -$1.0.
